Skip to content

Stilith Cardiac Pacemakers-M 60 & 120

by R.E. Brown Co., Inc.

510(k) K780781

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK780781 Date27 Jul 1978ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DXY
Device Class
Class III
Regulation
21 CFR Part 870.3610
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Stilith Cardiac Pacemakers-M 60 & 120 is an Implantable Pacemaker Pulse-Generator, a Class III medical device designed to regulate abnormal heart rhythms by delivering electrical impulses to the heart muscle. These pacemakers are intended for patients with bradycardia or other conduction disorders requiring consistent cardiac pacing to maintain proper heart function.

This device is supplied sterile and intended for single-use implantation, adhering to FDA 510(k) clearance (K780781) under the Cardiovascular advisory committee. Manufactured by R.E. Brown Co., Inc., it is regulated under the Implantable Pacemaker Pulse-Generator classification (DXY) and requires sterile handling prior to surgical implantation. No additional context on MRI safety, reusable components, or alternative sizes is provided in the regulatory data.

Other devices from R.E. Brown Co., Inc.

See all devices from R.E. Brown Co., Inc. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary purpose of the Stilith Cardiac Pacemakers-M. 60 & 120, and who would benefit from using it?

    The Stilith Cardiac Pacemakers-M. 60 & 120 are designed to regulate abnormal heart rhythms by delivering electrical impulses to the heart muscle. They are intended for patients with bradycardia or conduction disorders requiring consistent cardiac pacing to maintain proper heart function. This makes them suitable for individuals whose natural heart rate is too slow or irregular, ensuring stable cardiac output.

  • Are these pacemakers intended for single-use or reusable applications, and what does that mean for surgical planning?

    The Stilith Cardiac Pacemakers-M. 60 & 120 are explicitly labeled for single-use implantation. This means each device is sterile upon packaging and should not be reused after one surgical procedure. Clinicians must adhere to sterile handling protocols before implantation, as reuse could compromise patient safety and device efficacy.

  • How should these pacemakers be stored prior to use, and what precautions should be taken?

    Since the Stilith Cardiac Pacemakers-M. 60 & 120 are supplied sterile, they must be stored in their original packaging until immediately before implantation. The packaging should remain unopened and protected from contamination, moisture, or physical damage. Proper storage ensures sterility is maintained, which is critical for preventing post-operative infections or complications.

  • What regulatory pathway was followed for FDA clearance of this device, and what does that mean for clinicians?

    The Stilith Cardiac Pacemakers-M. 60 & 120 received FDA 510(k) clearance (K780781) under the Cardiovascular advisory committee, classified as a Class III device (Implantable Pacemaker Pulse-Generator). This means the device was deemed substantially equivalent to a legally marketed predicate, ensuring it meets established safety and performance standards. Clinicians can rely on this clearance as evidence of regulatory scrutiny, though they should always follow manufacturer instructions and local protocols for implantation.